Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Constantine A. Mantz"'
Autor:
Audrey T. Dang, MD, Rebecca G. Levin-Epstein, MD, David Shabsovich, BS, Minsong Cao, PhD, Christopher King, PhD, MD, Fang-I. Chu, PhD, Constantine A. Mantz, MD, Kevin L. Stephans, MD, Chandana A. Reddy, MS, D. Andrew Loblaw, MD, Patrick Cheung, MD, Marta Scorsetti, MD, Luca Cozzi, PhD, Albert S. DeNittis, MD, Yue Wang, MD, Nicholas Zaorsky, MD, Nicholas G. Nickols, MD, PhD, Patrick A. Kupelian, MD, Michael L. Steinberg, MD, Amar U. Kishan, MD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 3, Pp 404-411 (2020)
Purpose: To establish the safety and efficacy of gantry-mounted linear accelerator-based stereotactic body radiation therapy (SBRT) for low- and intermediate-risk prostate cancer. Methods: We pooled 921 patients enrolled on 7 single-institution prosp
Externí odkaz:
https://doaj.org/article/b429538fa8f34619b7a82eb247040b8e
Autor:
Jesus E. Juarez, MD, Tahmineh Romero, MS, Constantine A. Mantz, MD, Abigail Pepin, MD, Nima Aghdam, MD, Simeng Suy, PhD, Michael L. Steinberg, MD, Rebecca G. Levin-Epstein, MD, Nicholas G. Nickols, MD, PhD, Irving D. Kaplan, MD, Robert M. Meier, MD, Huong T. Pham, MD, Patrick W. Linson, MD, Robert L. Hong, MD, Mark K. Buyyounouski, MD, Hilary P. Bagshaw, MD, Donald B. Fuller, MD, Alan J. Katz, MD, Andrew Loblaw, MD, Sean P. Collins, MD, PhD, Amar U. Kishan, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100759- (2021)
Purpose: To evaluate the safety of stereotactic body radiation therapy (SBRT) for prostate cancer in men with inflammatory bowel disease (IBD). Methods and Materials: We queried a consortium database for patients with IBD receiving SBRT for prostate
Externí odkaz:
https://doaj.org/article/0cfef0a7088e43cd9b104465d13bc9c8
Autor:
Steven Eric Finkelstein, Robert Timmerman, William H. McBride, Dörthe Schaue, Sarah E. Hoffe, Constantine A. Mantz, George D. Wilson
Publikováno v:
Clinical and Developmental Immunology, Vol 2011 (2011)
Stereotactic radiation approaches are gaining more popularity for the treatment of intracranial as well as extracranial tumors in organs such as the liver and lung. Technology, rather than biology, is driving the rapid adoption of stereotactic body r
Externí odkaz:
https://doaj.org/article/047ef16552d34d5ea77fbbed8a98ec88
Autor:
Constantine A. Mantz, Nikhil G. Thaker, Curtiland Deville, Anne Hubbard, Praveen Pendyala, Najeeb Mohideen, Vivek Kavadi, Karen M. Winkfield
Publikováno v:
Journal of Racial and Ethnic Health Disparities. 10:501-508
Reduced access and utilization of radiation therapy (RT) is a well-documented healthcare disparity observed among racial and ethnic minority groups in the USA and a contributor to the inferior health outcomes observed among Black, Hispanic, and Nativ
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Autor:
John J Kresl, Clinton Medbery rd, Andrew Gaya, Richard D. Bucholz, Douglas J. Minnich, Alexander Muacevic, Anand Mahadevan, Joanne Davis, Constantine A. Mantz, Jun Yang, Hale Basak Caglar
Publikováno v:
Future Oncology. 10:2307-2310
The SRS/SBRT Scientific Meeting 2014, Minneapolis, MN, USA, 7–10 May 2014 The Radiosurgery Society®, a professional medical society dedicated to advancing the field of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), held
Autor:
Francisco A. Myslicki, Eduardo Fernandez, Daniel E. Dosoretz, Yosef Rotterman, Steven E. Finkelstein, Constantine A. Mantz, Jesse Shulman, Andre M. Agassi
Publikováno v:
Future Oncology. 10:2319-2328
ABSTRACT Radiation therapy and immunotherapy in partnership may have the capability of delivering a therapeutic effect exceeding the sum of its parts. The possible relationship has been demonstrated in murine models and has been extended to a variety
Autor:
Timothy D. Shafman, Christopher R. King, Constantine A. Mantz, Amy M. Dosoretz, Skyler B. Johnson, Sergio Faria, Alan Pollack, Jeffrey V. Brower, James B. Yu, Mark A. Ritter, Mikko Hallman, Matthew C. Abramowitz, Sean P. Collins, Steven E. Finkelstein, Cary P. Gross, Pamela R. Soulos, Patrick A. Kupelian, Simeng Suy, Eric M. Horwitz, Rudi Ross
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 121(2)
Evaluate changes in bowel, urinary and sexual patient-reported quality of life following treatment with moderately hypofractionated radiotherapy (5Gray/fraction) or stereotactic body radiation therapy (SBRT;5-10Gray/fraction) for prostate cancer.In a
Autor:
Joseph R, Evans, Shuang, Zhao, Stephanie, Daignault, Martin G, Sanda, Jeff, Michalski, Howard M, Sandler, Deborah A, Kuban, Jay, Ciezki, Irving D, Kaplan, Anthony L, Zietman, Larry, Hembroff, Felix Y, Feng, Simeng, Suy, Ted A, Skolarus, Patrick W, McLaughlin, John T, Wei, Rodney L, Dunn, Steven E, Finkelstein, Constantine A, Mantz, Sean P, Collins, Daniel A, Hamstra
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 116(2)
Background and purpose Stereotactic body radiotherapy (SBRT) is being used for prostate cancer, but concerns persist about toxicity compared to other radiotherapy options. Materials and methods We conducted a multi-institutional pooled cohort analysi
Autor:
Eduardo Fernandez, Constantine A. Mantz, N. Shore, Francisco A. Myslicki, Candice McCoy, Daniel E. Dosoretz, Steven E. Finkelstein, Mayer Fishman
Publikováno v:
Cancer control : journal of the Moffitt Cancer Center. 20(1)
Sipuleucel-T is an autologous cellular immunotherapy approved by the US Food and Drug Administration for the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. Its mechanism of action is based on stimu